Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 to 88

Using low contrast CT for planning heart valve replacement

Official title: Dual Energy CT Decreased IV Contrast Dose Imaging for TAVR

Run by University of Maryland, Baltimore · NCT05758701 · Data updated 2026-11-12

This study is testing if using less contrast dye in special CT scans can help doctors plan heart valve replacement surgery while keeping patients safer and saving money.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years to 88 Years
SexAll
Enrollment164 (estimated)
SponsorUniversity of Maryland, Baltimore
Academic / other
Locations1 site (Baltimore, Maryland)
StatusRecruiting
StartedSeptember 19, 2023
Main results expectedMarch 1, 2028
Study endsMarch 1, 2028
Registry record updatedJuly 1, 2026
Trial IDNCT05758701 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients scheduled to receive a TAVR abdominal CT.

Probably not a fit

Patients who cannot undergo a CT scan or have a GFR less than 30 will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the use of low-dose iodinated contrast in dual energy CT scans for patients scheduled to undergo transcatheter aortic valve replacement (TAVR). The aim is to determine if this method can effectively assist in presurgical planning while reducing the risk of acute kidney injury and addressing the shortage of iodinated contrast agents. By utilizing monoenergetic reconstruction techniques, the study seeks to optimize imaging quality with a lower volume of contrast. This approach could lead to significant cost savings for healthcare facilities and improve patient safety.

Why it matters

Potential benefit: If successful, this study could enhance the safety and efficiency of TAVR procedures by minimizing contrast-related complications.

How similar studies have gone: Other studies have explored low-dose contrast methods, but this specific approach using dual energy CT for TAVR planning is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* scheduled to receive TAVR abdominal CT

Exclusion Criteria:

* cannot undergo CT scan
* Allergy to intravenous contrast not controlled by steroids or benadryl
* GFR\<30

Where it's running

  • University of Maryland Medical Center
    Baltimore, Maryland, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.